Pfizer Inc. (NYSE: PFE) is set to showcase significant advancements in its hematology and breast cancer portfolios at the upcoming American Society of Hematology (ASH) Annual Meeting & Exposition (December 7-10) and the San Antonio Breast Cancer Symposium (SABCS, December…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on developing innovative treatments for urothelial and specialty cancers, has announced the presentation of the Phase 3 ENVISION trial’s efficacy and safety results at the Society of Urologic Oncology (SUO) annual…
MaaT Pharma, a clinical-stage biotechnology company specializing in Microbiome Ecosystem Therapies™ (MET) to improve cancer patient survival, announced the first treatment in the United States of a patient with acute Graft-versus-Host Disease (aGvHD) under the FDA’s Single Patient Expanded Access…
MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced today the initiation of the Phase I/II clinical trial for JR-446 in Japan, with the first participant dosed. JR-446 is a proprietary α-N-acetylglucosaminidase designed to…
SOLVE FSHD, a venture philanthropy organization focused on accelerating new therapies for facioscapulohumeral muscular dystrophy (FSHD), is inviting innovators from around the globe to compete for the USD$10 million FSHD Bonus Prize. This prize is part of the XPRIZE Healthspan…
Cencora, a global healthcare leader, has introduced Accelerate Pharmacy Solutions, a comprehensive suite of services aimed at helping hospital and health system customers streamline operations and improve financial performance. This new portfolio consolidates Cencora’s pharmacy and supply chain solutions, providing…
VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions known for its scalable technology and clinical expertise, has partnered with AbundaBox to launch AbundaLife™, an innovative health record management platform. AbundaLife addresses the challenge of fragmented medical records by…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced that 10 of its abstracts have been selected for poster presentations, and two will be featured for online publication at the 66th American Society of Hematology (ASH) Annual…
Parse Biosciences, a leader in accessible and scalable single-cell sequencing solutions, has announced the creation of the world’s largest single-cell dataset to date, comprising 100 million cells. This milestone was achieved in just one month using Parse Biosciences’ GigaLab platform,…
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced that its Decipher Prostate Genomic Classifier is now the only gene expression test included in version 1 of the 2025 NCCN® Clinical Practice Guidelines in Oncology (NCCN Guidelines®). It is…